eosine yellowish-(ys) has been researched along with Cardiac Hypertrophy in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 3 (100.00) | 2.80 |
Authors | Studies |
---|---|
Liu, L; Luo, M; Mou, Q; Tian, J | 1 |
Fan, LN; Han, C; Hu, R; Li, J; Li, XJ; Liu, LW; Ma, H; Ta, SJ; Wang, B; Wu, JF; Zhou, MY; Zuo, L | 1 |
Qu, H; Xu, R; Zhang, W; Zhang, Y; Zhu, Y | 1 |
3 other study(ies) available for eosine yellowish-(ys) and Cardiac Hypertrophy
Article | Year |
---|---|
Treg/Th17 Ratio Regulation May Play an Important Role in Epigallocatechin-3-Gallate-Mediated Attenuation of Increased Afterload-Induced Cardiac Hypertrophy.
Topics: Animals; Cardiomegaly; Catechin; Disease Models, Animal; Eosine Yellowish-(YS); Hematoxylin; Male; Mice; Mice, Inbred C57BL; T-Lymphocytes, Regulatory; Th17 Cells; Wheat Germ Agglutinins | 2022 |
[Myocardial biopsy of Liwen procedure: representability and etiological diagnostic value of cardiac samples obtained by a novel technique in patients with hypertrophic cardiomyopathy].
Topics: Biopsy; Cardiomegaly; Cardiomyopathy, Hypertrophic; Eosine Yellowish-(YS); Fibrosis; Heart Defects, Congenital; Hematoxylin; Humans; Lipofuscin; Male; Myocardium; Retrospective Studies | 2022 |
Knockout of cardiac troponin I-interacting kinase leads to cardiac dysfunction and remodelling.
Topics: Animals; Apoptosis; Cardiomegaly; Caspase 3; DNA Nucleotidylexotransferase; Eosine Yellowish-(YS); Heart Diseases; MAP Kinase Kinase Kinases; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; p38 Mitogen-Activated Protein Kinases; Protein Serine-Threonine Kinases; Troponin I; Wheat Germ Agglutinins | 2022 |